A Worldwide Gold Lockdown Is Now Underway
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Financials
| Curr Year EPS Estimate | -3.27 |
| Next Quarter EPS Estimate | -1.09 |
| Profit Margin | -117.20% |
| Operating Margin | -130.91 |
| Return on Assets | -0.28 |
| Return on Equity | -1.48 |
| Revenue | 33.3M |
| Earnings Per Share | -5.56 |
| Revenue Per Share | 4.74 |
| Gross Profit | -25,524,000 |
| Quarterly Revenue Growth | 0.13 |
General
| Name | Assembly Biosciences Inc |
| Ticker | ASMB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 73 |
About Assembly Biosciences Inc
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
Earnings
Louisiana judge orders review of Gulf Coast liquefied natural gas facility's climate change impacts
NEW ORLEANS (AP) — A Louisiana judge has tossed out a key permit for a liquefied natural gas facility that won approval from , ordering a state review of how the facility's planet-warming emissions would affect Gulf Coast communities vulnerable to sea-level rise and extreme weather.
Trump Commutes Former Rep. George Santos' Seven-Year Prison Term: '... Has Been Horribly Mistreated'
President Donald Trump announced on Friday that he commuted the prison sentence of former congressman George Santos (R-N.Y.), ordering his immediate release.
Indiana Teacher's Son Stumbles on Cancer Breakthrough? - Ad
This ordinary son worked on the Manhattan Project and won a Nobel Prize. But he would eventually create one of the strongest natural cancer solutions known to man. Powerful interests have kept this hidden from cancer patients for decades. But today one brave doctor is finally exposing the truth.
CSX profit falls 22% as new CEO takes over but performance is expected to improve
CSX's earnings fell 22% in the third quarter as the railroad wrapped up two major construction projects that were limiting traffic, but volume was still up slightly and the results were weighed down by a one time charge.
Pam Bondi Says Meta Removed Facebook Page Used To 'Dox And Target' ICE Agents: 'Wave Of Violence' Against ICE Driven By Online Apps
Meta removed a Facebook page accused by the Justice Department of being used to "dox and target" ICE agents in Chicago, following similar actions by Apple and Google amid rising controversy over President Donald Trump's immigration enforcement tactics.
A Worldwide Gold Lockdown Is Now Underway - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Dave Ramsey Doesn't Mess Around With Bitcoin Or Gold, Says 'I Have Three Investments' — Here's What They Are
Personal finance expert Dave Ramsey has long dismissed crypto, gold and single-stock investing, calling them risky distractions — but new research shows that his disciplined mutual fund approach may have cost him market-beating returns.
Is college worth the cost? Universities work to show the return on investment of a degree
WASHINGTON (AP) — For a generation of young Americans, choosing where to go to college — or — has become a complex calculation of costs and benefits that often revolves around a single question: Is the degree worth its price?
The Next Biggest Bull Run In Over 50 Years - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Boeing's 737 Momentum Fuels Delivery Surge, Embraer Stays On Track
Commercial aerospace regains altitude in Q3 as Boeing, Embraer, and Airbus show improving production stability and rising delivery momentum.
Platinum's Incredible Rally Surprises Even The Insiders
Platinum has surged above $1,650/oz, making it 2025's best-performing precious metal. Demand in China and supply constraints are driving the rally.
Shocking Elon Move: Bigger Than DOGE? - Ad
After blowing everyone's mind with his recent DOGE moves, what Elon Musk is about to do next will not only shock the world... But it could also put an extra $30,000 a year in your pocket.
Tim Cook To Depart, Steve Jobs' Lesson For Guy Kawasaki And More: This Week In Appleverse
From executive shake-ups at Apple to TSMC's revenue surge and Goldman's take on the AI boom, here are the top Apple stories.
Australian Oilseeds Holdings Shares Soar 248% After Hours Amid Trump Says US Will Make Its Own Cooking Oil
Australian Oilseeds Holdings surged 248% after Trump's trade threat against China sparked a rally in agricultural biotech stocks.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
BlackRock To Launch Revamped Money Market Fund For Serving Stablecoin Issuers
BlackRock introduces redesigned money market fund, BSTBL, for stablecoin issuers under newly enacted GENIUS Act. Complements broader digital asset strategy.
USA Rare Earth (USAR) Stock Is Rising Today: Here's Why
Shares of USA Rare Earth, Inc. (NASDAQ: USAR) are trading higher Monday amid a wave of optimism for rare earth materials companies.
RFK Jr to Be Fired? - Ad
On October 7, six former US Surgeon Generals published a letter trying to get RFK Jr. fired. Most of them have direct ties to the $1.7 TRILLION pharmaceutical industry. It makes you wonder... What are they all so darn worried about?
US Treasury Teases Commemorative Trump $1 Coin With 'Fight, Fight, Fight' Slogan — But Legal Hurdles May Block Release
The U.S. Treasury announced on Friday plans to mint a new $1 coin featuring President Donald Trump, to commemorate 250 years since the declaration of American independence in 2026.
Ethereum Crashes To $4,100 As Senate Democrats Take Aim At DeFi
Ethereum (CRYPTO: ETH) is trading near $4,100 on Friday, after a sharp selloff that followed its rejection from $4,700 and renewed fears of U.S.
Robert F. Kennedy Jr BOMBSHELL - Ad
Have you seen THIS shocking RFK Jr story? The corrupt mainstream media won't dare breathe a word about it... Yet this controversy is harming the brains of millions of Americans aged 65+...
Regeneron's Gene Therapy Shows Significant Gains In Genetic Hearing Loss
Regeneron gene therapy for OTOF-related hearing loss shows rapid, sustained improvements, including normal hearing in some participants.
Corpay And Mastercard Just Made Global Payments Faster
Corpay, Inc. (NYSE: CPAY) and Mastercard Inc. (NYSE: MA) said on Monday they are
THE LIST is Out - Ad
A covered-up LIST has just been revealed... And it's even more damning than we ever could've imagined. I'm talking about corruption at the highest levels of government... And now they're all FINALLY exposed.
Exxon To Beat Q3 Expectations Despite Lower Commodity Prices: JP Morgan
JP Morgan remains bullish on ExxonMobil, setting a $124 target and forecasting Q3 EPS of $1.86, slightly above market expectations.
Trump administration puts on hold $18 billion in funding for New York City infrastructure projects
WASHINGTON (AP) — President Donald Trump's administration said Wednesday it was putting a hold on roughly $18 billion to fund beneath the Hudson River between New York City and New Jersey and the city's expanded project because of .
RFK Jr Just Dropped a Bombshell on Big Pharma Elites - Ad
RFK Jr just took dead aim at Big Pharma... and he is NOT messing around. Big Pharma is HORRIFIED and their #1 fear may be about to come true. RFK Jr is now poised to EXPOSE Big Pharma's biggest secret.
Tesla Stock Is 'Mooning'—Thank Elon? (CORRECTED)
Tesla stock has risen approximately 152% since Musk announced he was leaving D.C., rising from $182 on May 24 to close at $459 on Oct. 1.
Trump Administration Withdraws Brian Quintenz's Nomination For CFTC Chair, Says President Prioritizes Making America 'Crypto Capital' Of The World
The Trump administration has pulled back the nomination of Brian Quintenz for the chair of the Commodity Futures Trading Commission, a White House official told Benzinga late Tuesday.
Big Food is ATTACKING RFK Jr - Ad
After announcing a ban on using govt welfare for sugary drinks, Big Food launched an all-out assault on RFK Jr. But it's nothing compared to the fight Big Pharma is likely preparing. RFK Jr is poised to reveal their biggest secret and Big Pharma will stop at nothing to keep it hidden.
Retail Investors Gain Access To Private Credit Market Via This New ETF
Simplify Asset Management and VettaFi have introduced a new exchange-traded fund (ETF) that enables retail investors to tap into the rapidly growing private credit market.
Elizabeth Warren Says Trump Is 'Plotting' To Reduce Social Security Benefits For Older Americans: 'We Must Call It Out And Stop These Cuts'
Sen. Warren accuses Trump of planning to cut Social Security benefits for older Americans, citing a report and ongoing debate. Trump denies it.
RFK Jr To Senator: "YOU ARE LYING!" - Ad
At a recent Senate firing squad, RFK Jr boldly stood up to Senator Hassan and declared right to her face, "You are lying!" His fight's getting more intense every day... But the general public still might not be ready for THIS. Either way, this could be the SCARIEST health crisis of our time.
Can a Taxable Account Beat a 401(k)?
Being advised to max out your 401(k)is Personal Finance 101. But is that universally solid guidance?
China outlines more controls on exports of rare earths and technology
HONG KONG (AP) — China outlined new curbs on exports of rare earths and related technologies on Thursday, extending controls over use of the elements critical for many products ahead of a meeting later this month between President Donald Trump and Chinese leader Xi Jinping.
Released: Manhattan Project's Cancer Breakthrough - Ad
The Manhattan Project, the greatest scientific endeavor of the 20th Century, led to a cancer breakthrough from its research. This Nobel Prize-winning discovery helps stop cancer in its tracks-Naturally, safely, and without chemo.
New York Times, AP, Newsmax among news outlets who say they won't sign new Pentagon rules
News organizations including The New York Times, The Associated Press and the conservative Newsmax television network said Monday they will not sign a Defense Department document about its new press rules, making it likely the Trump administration will evict their reporters from the Pentagon.
SWIFT Taps Ethereum Layer-2 Chain Linea, Bitcoin's Fall, Mark Cuban's Bitcoin ETF Observation And More: This Week In Crypto
It’s been quite a week in the world of cryptocurrency. From SWIFT’s decision to use Ethereum’s Layer-2 blockchain for stablecoin testing to Bitcoin’s price drop, here’s a quick recap of the top stories from the weekend.
What Neil Armstrong REALLY Saw on the Moon [TERRIFYING] - Ad
You won't see THIS in any history book... But after becoming the first man to set foot on the moon... Neil Armstrong reported a strange encounter he had in space during a post-mission debrief. NASA did their best to keep it secret... But now, unearthed NASA audio is blowing the lid off of everything.
What's Behind The Sharp 39% After-Hours Rally In Telomir Pharmaceuticals?
Telomir's stock jumped nearly 39% in after-hours trading following news that its lead compound, Telomir-1, showed potential in reversing cancer-related DNA changes in aggressive prostate cancer models.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.